Multiple Target-Specific Molecular Imaging Agents Detect Liver Cancer in a Preclinical Model

Current Molecular Medicine - United Arab Emirates
doi 10.2174/156652412802480952
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Translocator Protein PET Imaging in a Preclinical Prostate Cancer Model

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2017English

Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging

Current Molecular Imaginge
2012English

RK-287107, a Potent and Specific Tankyrase Inhibitor, Blocks Colorectal Cancer Cell Growth in a Preclinical Model

Cancer Science
Cancer ResearchMedicineOncology
2018English

New Developments in Dual-Labeled Molecular Imaging Agents

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

Asialoglycoprotein Receptor (ASGPR): A Peculiar Target of Liver-Specific Autoimmunity

Autoimmunity Highlights
RheumatologyImmunology
2012English

Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple Sclerosis

Frontiers in Immunology
AllergyImmunology
2016English

Metformin in Colorectal Cancer: Molecular Mechanism, Preclinical and Clinical Aspects

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Molecular Imaging of N-Linked Glycosylation Suggests Glycan Biosynthesis Is a Novel Target for Cancer Therapy

Clinical Cancer Research
Cancer ResearchOncology
2010English

Identification of CETP as a Molecular Target for Estrogen Positive Breast Cancer Cell Death by Cholesterol Depleting Agents

Genes and Cancer
Cancer ResearchGenetics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy